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Doppler ultrasound is a non-invasive method for evaluating vascularization and is widely used in clinical practice.
Gestational trophoblastic neoplasia includes a group of highly vascularized malignancies derived from placental
cells. This review summarizes data found in the literature regarding the applications of Doppler ultrasound in
managing patients with gestational trophoblastic neoplasia. The PubMed/Medline, Web of Science, Cochrane and
LILACS databases were searched for articles published in English until 2014 using the following keywords:
‘‘Gestational trophoblastic disease AND Ultrasonography, Doppler.’’ Twenty-eight articles met the inclusion criteria
and were separated into the 4 following groups according to the aim of the study. (1) Doppler ultrasound does not
seem to be capable of differentiating partial from complete moles, but it might be useful when evaluating
pregnancies in which a complete mole coexists with a normal fetus. (2) There is controversy in the role of uterine
artery Doppler velocimetry in the prediction of development of gestational trophoblastic neoplasia. (3) Doppler
ultrasound is a useful tool in the diagnosis of gestational trophoblastic neoplasia because abnormal myometrial
vascularization and lower uterine artery Doppler indices seem to be correlated with invasive disease. (4) Lower
uterine artery Doppler indices in the diagnosis of gestational trophoblastic neoplasia are associated with
methotrexate resistance and might play a role in prognosis.
CONCLUSION: Several studies support the importance of Doppler ultrasound in the management of patients with
gestational trophoblastic neoplasia, particularly the role of Doppler velocimetry in the prediction of trophoblastic
neoplasia and the chemoresistance of trophoblastic tumors. Doppler findings should be used as ancillary tools, along
with human chorionic gonadotropin assessment, in the diagnosis of gestational trophoblastic neoplasia.
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’ INTRODUCTION
Gestational trophoblastic disease includes a spectrum of
conditions characterized by abnormal trophoblast proliferation
and invasion. It primarily comprises five diseases: hydatidiform
mole, invasive mole, choriocarcinoma, placental site trophoblas-
tic tumor and epithelioid trophoblastic tumor. Hydatidiform
mole is the most common form, with an estimated incidence of
1 case in 1,000 pregnancies. Although it is generally a benign
condition, it can evolve into an invasive form in some patients.
The remaining diseases are all malignant forms termed gesta-
tional trophoblastic neoplasia (GTN) or gestational trophoblastic
tumors. These tumors are highly vascularized and, in the past,
were often evaluated by arteriography (1).
Doppler ultrasonography is a noninvasive method cur-
rently used to reliably evaluate and measure blood flow.
Doppler ultrasound includes color, power and spectral
modalities. Color flow imaging evaluates the direction of
blood flow and is based on a frequency change. In contrast,
power Doppler is based on amplitude changes and is thus
more sensitive to slow velocity flows but does not provide
direction information. Spectral Doppler provides a functional
assessment of the circulation by calculating Doppler veloci-
metry indices based on the waveforms of blood flow. The
most commonly used Doppler indices are the ratio of peak
systolic to end diastolic velocity (S/D), resistance index (RI;
calculated as [peak systolic velocity - end diastolic velocity /
peak systolic velocity]) and pulsatility index (PI, calculated
as [peak systolic velocity - end diastolic velocity / mean
velocity]) (2).
It has been shown that Doppler ultrasonography presents
almost the same findings (tumor size and localization) as a pelvicDOI: 10.6061/clinics/2015(12)08
Copyright & 2015 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons License (http://creativecommons.org/licenses/by/
4.0/) which permits unrestricted use, distribution, and reproduction in any
medium or format, provided the original work is properly cited.
No potential conflict of interest was reported.
810
REVIEW
arteriogram in women with GTN and this approach is currently
widely used and substituted arteriography in the evaluation of
such patients (1,3). Below, we summarize the main purposes of
Doppler sonography in the management of patients with
gestational trophoblastic disease.
’ METHODS
The PubMed/Medline, Web of Science, Cochrane and
LILACS databases were searched for articles published in
English until 2014 using the following Medical Subject
Heading (MeSH) keywords: ‘‘Gestational trophoblastic dis-
ease AND Ultrasonography, Doppler.’’ Studies evaluating
the role of Doppler ultrasound in the diagnosis, prognosis
and follow-up of patients with gestational trophoblastic
disease were included. Case reports, reviews, letters to the
editor and articles not in English were excluded. All abstracts
were analyzed and included according to the current study
criteria. The selected articles’ bibliographies were also evaluated
and the relevant references were included.
’ RESULTS AND DISCUSSION
The initial search identified 103 articles in PubMed, 35 in
Web of Science, and no articles in the Cochrane and LILACS
databases. Twenty-eight articles were selected for this review
according to the inclusion and exclusion criteria (Figure 1).
The articles were divided into 4 groups according to the aim
of the study.
Doppler evaluation for the differentiation of
partial and complete moles
Differentiating between partial and complete moles carries
prognostic significance because of the higher rate of post-molar
disease in complete moles (15-20%) compared with partial
moles (less than 5%). In most cases, ultrasonography can
identify the type of mole. However, in certain situations (such
as a complete mole with a coexisting normal fetus), ancillary
methods such as Doppler ultrasound are useful.
In a retrospective study, a higher RI of the uterine arteries
(UA) was reported in normal pregnancies (n=13; mean
RI=0.66±0.05) compared with molar pregnancies, but there
was no significant difference between the UA RI of partial moles
(n=33; mean RI=0.56±0.04) and complete moles (n=106; mean
RI=0.55±0.06) (4). Jauniaux et al. (1996) described a series of
70 cases of triploidy after the first trimester and demonstrated
that at least half of the cases with a UA evaluation (n=41)
presented with an abnormally high RI (5). In a series of cases
presented by Jauniaux & Nicolaides, the UA PI after 16 weeks
was below the fifth percentile in all three complete moles that
coexisted with a normal fetus, in contrast with a uterine artery
PI within normal ranges in six cases of partial moles (6).
Trophoblastic cells at the implantation site of each type of
pregnancy seem to differ according to the level of invasiveness
observed in the first trimester of molar pregnancies, particularly
in complete moles (7), which might explain the difference in
Doppler velocimetry of the UA. In clinical practice, the values
of the UA Doppler indices do not seem to help differentiate
between partial and complete moles, except when complete
moles coexist with a normal fetus.
Doppler ultrasound in the prediction of GTN
There are few predictors of the clinical course of hydatidi-
form moles. Advanced maternal age, higher human chorionic
gonadotropin (hCG) levels, larger uterine size, complete moles,
large theca lutein cysts and clinical complications have been
associated with malignant post-molar disease. Few studies
have evaluated the role of Doppler ultrasound in the prediction
of GTN development.
Figure 1 - Flow chart describing the mechanism of search.
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Lower UA Doppler indices before molar evacuation were
associated with the development of GTN in 5 patients (mean
S/D=5.10; mean RI=0.80; mean PI=1.82) compared with
16 patients who exhibited spontaneous remission (mean
S/D=2.27; mean RI=0.55; mean PI=0.86) (8). Similarly, Gungor
et al. (1998) reported a lower UA RI before molar evacuation in
12 patients who developed persistent malignant disease (mean
RI=0.29) compared to 20 patients with spontaneous remission
(mean RI=0.46) (9). In contrast, the study by Chan et al. (1996)
showed no difference in the UA RI in 11 patients with
spontaneous remission compared with 21 patients with post-
molar disease (10). A preliminary study that included 8 patients
reported that a lower UA PI (o1.5) after 2 weeks of evacuation
was only observed in the 2 patients with GTN prior to the hCG
increase (11).
Doppler ultrasound seems to play a role in predicting
GTN following uterine evacuation. In a retrospective cohort,
the presence of Doppler ultrasound abnormalities, such as
nodules or hypervascularization in the myometrium or
endometrium, after 3 weeks of molar evacuation was highly
correlated with the development of GTN in 14 patients
compared to 175 patients who exhibited spontaneous
remission (12). Zanetta et al. (13) evaluated the efficiency of
uterine morphology and Doppler ultrasound in the diag-
nosis of post-molar disease. The Doppler results were
considered abnormal when at least three vessels in the
myometrium or residual intrauterine tissue had a PI below
1.0. In 16 patients with spontaneous regression of hCG, the PI
values showed progressive increases, and the vascularization
was reduced during follow-up. Normal Doppler findings had a
negative predictive value of 100% for persistent disease, and
normalization of the findings occurred up to 8 weeks before
hCG became undetectable. In contrast, an abnormal Doppler at
the 6th week post-evacuation showed a positive predictive
value of 67% for local persistence. In a follow-up of 9 patients
with GTN, only one patient presented with normal ultra-
sound findings and elevated hCG, which was related to
extra-uterine metastasis (13).
Although most studies have noted that a lower resistance in
the UA is associated with the development of trophoblastic
tumors (Table 1), data in the literature remain controversial. New
studies with larger samples are thus needed to better elucidate
the role of Doppler ultrasound in predicting post-molar disease.
Post-molar follow-up and diagnosis of
trophoblastic neoplasia
Following uterine molar evacuation, patients are fol-
lowed closely with weekly clinical evaluations and hCG
monitoring. An ultrasound is only generally needed when
there is an increase or plateau in hCG titers when evaluat-
ing a primary GTN site. Using Doppler ultrasonography
to detect post-molar disease was found to be more
efficient, primarily in microscopic disease compared with
standard ultrasound scans, in a series of patients with
persistent trophoblastic disease who underwent dilation
and curettage (14).
Emoto & Sadamori (15) described the presence of
intratumoral blood flow by color Doppler ultrasonography
in all forms of trophoblastic tumors (5 invasive moles,
1 choriocarcinoma and 1 placental site trophoblastic tumor),
whereas this observation was not made in 15 hydatidiform
moles. Moreover, after contrast enhancement using a
Levovist microbubble contrast agent, there was a significant
increase in flow in the small invasive moles (o2 cm) (15).
A large retrospective study of 355 patients with tropho-
blastic disease reported a higher UA RI in normal pregnan-
cies (n=13; mean RI=0.66), followed by partial (n=33;
RI=0.56) and complete hydatidiform moles (n=106; mean
RI=0.55), compared to GTN pregnancies (mean RI=0.28 and
RI=0.25 for 184 presumed invasive moles and 32 chor-
iocarcinomas, respectively) (4). In other studies, it was
shown that patients with trophoblastic tumors had a lower
resistance on UA Doppler than did those with a hydatidi-
form mole or women who were post-abortion, non-
pregnant or in the first trimester of pregnancy (Taylor
et al. (16); Long et al. 1990; Tepper et al. (18); Chan et al.
(10); Hsieh et al. 1994) (Table 2).
There is also evidence of a strong correlation between UA
Doppler indices and hCG regression patterns in hydatidiform
moles and post-molar tumors, with a concurrent increase in the
Doppler indices and a decrease in hCG after uterine evacuation
(8,10,13,18,20,21).
The blood flow area ratio (BFAR) is a way to quantify
blood flow in an area of interest using appropriate software
based on 2D power Doppler sonography. The BFAR in
19 patients with invasive trophoblastic disease was signifi-
cantly higher than in 25 women with a normal pregnancy or
25 non-pregnant individuals. It was also demonstrated that
the BFAR gradually decreased during and after chemother-
apy, but it took 3 to 6 months after chemotherapy to
normalize in value (22).
Hsieh et al. (23) described three different vascular
patterns for Doppler ultrasound in 28 trophoblastic
tumors: diffuse, lacunar and compact. These patterns
showed different UA RI (more compact and fewer lacunar
type), hCG levels (more compact and fewer diffuse type)
and the need for more than 5 chemotherapy cycles (more
compact and fewer diffuse type). Histopathological ana-
lysis was available in 11 cases; of these, 7 invasive moles
Table 1 - Studies that evaluated the correlation between UA Doppler indices and the development of post-molar trophoblastic tumors
before uterine evacuation. n: number of patients; S/D: systolic/diastolic velocity; PI: pulsatility index; RI: resistance index.
Study Patients with spontaneous
remission
Patients with persistent disease Conclusion
n S/D PI RI n S/D PI RI
Yalcin et al., 2001 16 5.1 1.82 0.8 5 2.27 0.86 0.55 Lower uterine artery indices (S/D, PI, RI) before uterine
evacuation were associated with persistent disease
(po0.01).
Gungor et al., 1998 20 - - 0.46 12 - - 0.29 Lower uterine artery RI before uterine evacuation
was associated with persistent disease (po0.001).
Chan et al., 1996 11 - - 0.76 21 - - 0.69 No association between uterine artery RI before
uterine evacuation and persistent disease.
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were the lacunar type, and 4 choriocarcinomas were the
compact type, which indicated that on some level, Doppler
ultrasound is capable of differentiating trophoblastic
tumors (23).
Doppler ultrasound seems to be a useful adjuvant tool in
post-molar follow-up and GTN diagnosis because it has been
well-demonstrated in the literature that abnormal Doppler
findings evaluated using different methods (such as
abnormal myometrial vascularization and lower UA
Doppler indices) are correlated with invasive disease.
Increased vascularization of the myometrium, higher UA
peak systolic velocity, and lower UA RI and PI were all
associated with GTN, although the Doppler indices varied
between studies (Table 2). Additional useful information
for follow-up includes an inverse correlation between UA
Doppler indices and hCG regression. However, some
caution should be taken when analyzing abnormal
Doppler images alone after uterine evacuation or che-
motherapy because of the development and persistence of
arteriovenous communications in the myometrium; in
these cases, the hCG level is normal (13).
Prediction of resistance to chemotherapy
Several studies have demonstrated a rough correlation
between uterine Doppler vascularization and the response
to chemotherapy (3,24). A pilot study assessed ultrasound
and Doppler signs of response (decreases in tumor size,
echogenicity and abnormal myometrial Doppler signal) in
seven patients with chemoresistance to methotrexate sus-
pected by an hCG plateau. Three of these patients had
ultrasound findings that indicated a response and achieved
remission after methotrexate. This study suggests that an
ultrasound can differentiate patients with a delayed res-
ponse to methotrexate from those who require second-line
treatment (25).
An increase in the UA Doppler indices of patients
responding to chemotherapy was observed in parallel with
a decrease in hCG levels (18). Although the initial UA S/D
ratio was not significantly different between the 16 patients
with chemoresistant (2.69±1.8) and chemosensitive disease
(2.72±1.31), after the completion of chemotherapy, the UA
S/D ratio increased only in patients with remitted disease
(6.23±2.38). However, this was not observed in patients with
non-remitted disease (3.08±1.54) (26).
Hsieh et al. (19) described a higher mean UA RI in 10
patients requiring fewer than 5 cycles of chemotherapy
(mean RI=0.71±0.09) compared with 13 patients who
required longer chemotherapy (mean RI=0.47±0.14). In
addition, there was an evident decrease in the peak systolic
velocity after the first three chemotherapy cycles in the group
that required fewer courses of treatment (54.2 to 23.6)
compared to the other group (60.1 to 60) (23). These findings
indicate a greater change in uterine hemodynamics in
patients with a better response to chemotherapy, which
could help in the decision to change chemotherapy.
Deeper myometrial invasion and lower RI from myome-
trial vascularization were correlated with methotrexate
resistance in 37 patients with GTN. Thirty patients showed
remission with a single chemotherapy agent, whereas
7 patients required an actinomycin D combination chemo-
therapy or hysterectomy. A cuff-off value of 4 cm or higher
for myometrial invasion (sensibility 100% and specificity
75%) and a myometrial vascularization RIp0.28 (sensibility
87.5 and specificity 83.3) were proposed to predict single-
agent chemotherapy resistance (27).
Several studies have evaluated the prediction of methotrex-
ate resistance with UA PI prior to chemotherapy. Long et al.
(17) prospectively evaluated the UA PI of 40 patients with
GTN and proposed a PI cut-off value ofp1.1 for inclusion in
the prognostic scoring system of trophoblastic tumors due to
the elevated likelihood of these patients developing chemore-
sistance (28). In a retrospective study of 164 patients, the UA
PI was an independent factor for methotrexate resistance. A
PIp1.0 detected resistance with a sensitivity of 68% and
specificity of 62%, with an adjusted odds ratio of 2.27 for
methotrexate resistance. Furthermore, 72.2% of the patients
with a Charing Cross Hospital prognostic score between 6 and
8 and a PIp1 developed resistance. In contrast, only 20% of
the patients with a PI41 developed resistance (29). Similarly,
the UA PI was identified as an important factor associated
with methotrexate resistance in 73 patients with a GTN FIGO
score of 5-6. A chemoresistance risk of 67% was calculated for
patients with UA PIp1, compared to 42% when the UA PI
was41 (p=0.036) (30). Another study that assessed the UA PI
and methotrexate resistance in 239 patients with a FIGO score of
0-6 showed a lower UA PI in patients with chemoresistance and
found that a UA PIp1 served as a risk factor, independent of the
FIGO scoring system for methotrexate resistance. Patients with a
FIGO score of 6 and UA PIp1 showed 100% resistance to
methotrexate compared with 20% of the patients who had a UA
PI41. The authors suggest that these patients might benefit from
upstaging and combination therapy (31).
Numerous studies support the utilization of Doppler
ultrasound as a tool to predict chemotherapy resistance
(Table 3). In particular, qualitative Doppler assessment might
help in managing patients with a plateaued hCG. More
Table 2 - Studies that evaluated the UA RI in gestational trophoblastic disease, normal pregnancy and non-pregnant women.
GTN: gestational trophoblastic neoplasia; HM: hydatidiform mole; n: number of patients; UA RI: uterine artery resistance index;
CC: choriocarcinoma; IM: invasive mole; CHM: complete hydatidiform mole; PHM: partial hydatidiform mole.
Study GTN HM Pregnant Non-pregnant Conclusion
n UA RI n UA RI n UA RI n UA RI
Tepper et al.,
1994
3 0.410 ± 0.04 - - 20 0.494 ± 0.06 - - Lower UA RI in GTN compared with
first-trimester pregnant woman
Chan et al.,
1996
32 0.68 ± 0.16 - - 18 0.8 ± 0.09 23 0.9 ± 0.08 Lower UA RI in GTN compared with
non-pregnant and first-trimester
pregnant woman
Hsieh et al.,
1994
23 0.56 ± 0.19 15 0.75 ± 0.06 - - 55 0.80 ± 0.05 Higher peak systolic velocity and lower
UA RI in GTN compared with
non-pregnant and
post-evacuation uneventful moles
Zhou et al.,
2005
32 (CC)
184
(IM)
0.25± 0.05 (CC)
0.28 ± 0.06 IM)
106
(CHM)
33 (PHM)
0.55 ± 0.06
(CHM)
0.56± 0.04 (PHM)
13 0.66 ± 0.05 - - Lower UA RI in GTN compared with
hydatidiform moles and first-trimester
pregnant woman
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importantly, evaluating UA Doppler indices seems to be a
promising marker to predict methotrexate resistance. How-
ever, more studies are needed to fully understand the role of
Doppler ultrasound in the prognostic risk evaluation of
trophoblastic tumors.
Doppler ultrasound has several applications in evaluating
patients with gestational trophoblastic disease. Its role in
differentiating the type of molar pregnancy and predicting
trophoblastic neoplasia might aid clinicians in the manage-
ment and counseling of patients. However, more studies are
needed to better evaluate these findings. Recent data also
support the use of Doppler as an important ancillary tool in
post-molar follow-up, particularly using UA PI values to
predict methotrexate resistance.
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